Executive Summary
The October 7, 2026, board room change filings reveal a significant wave of corporate restructuring and leadership transitions across the US market, with a notable concentration in the industrial and technology sectors.
The most critical development is Corteva's successful spin-off of its seed business into Vylor Inc., a major strategic move that triggered a complete board and C-suite overhaul, representing the highest materiality event in this batch. A clear pattern of orderly CFO transitions is evident, with FuelCell Energy, Alkami Technology, and Advasa Holdings all announcing CFO changes with structured transition periods, suggesting proactive succession planning rather than crisis-driven departures. The data also shows a trend of appointing directors with deep operational and regulatory expertise, such as Dr. Jeong H. Kim at Crane NXT (former Bell Labs President) and Donald Slager at WillScot (former Republic Services CEO), signaling a focus on governance strengthening. While no period-over-period financial comparisons were available in these specific filings, the forward-looking data on executive compensation packages (e.g., Hims & Hers' $3M RSU grant to new CAO) and separation agreements (e.g., Matternet's $156K CFO severance) provide actionable intelligence on company financial health and talent retention strategies. The mixed sentiment at BiomX/Tessera, with its going concern qualification and performance-based CEO equity awards, represents the highest-risk situation requiring immediate investor attention.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from September 29, 2026.
Investment Signals (10)
-
Completed spin-off of seed business (Vylor Inc.) on Oct 1, 2026, with full board and C-suite refresh; new CEO Luke Kissam appointed, signaling a clean slate for the remaining crop protection business [BULLISH - strategic focus]
-
Appointed new CAO with $3,000,000 RSU grant and $150,000 signing bonus; strong talent acquisition from Rivian suggests confidence in growth trajectory and internal controls [BULLISH - talent investment]
-
CFO transition with outgoing CFO Michael Bishop retained as Senior Advisor through April 2027 at $461,591 salary; new CFO from Xylem/Deloitte with $460K base + $120K sign-on bonus + $400K RSUs [BULLISH - orderly succession, strong hire]
-
Appointed Joseph M. Fitzgerald as COO effective Jan 1, 2027, with new segment structure (Interventional Therapies, Rhythm Solutions, MedSurg); signals operational efficiency push and faster decision-making [BULLISH - growth enablement]
-
CEO Michael Oster awarded 1M options at $1.15, 1M RSUs, 400K vested shares, and performance-based EBITDA awards for FY2027/FY2028; company raised $6M+ via ATM and secured $5M credit line [BULLISH - strong incentive alignment if turnaround succeeds]
-
Former CEO Lin Li selling all 1,803,750 common shares and 625,000 Series A Preferred shares to third-party investor; new independent director Vincent La Scala (ex-Citi, 30+ years) appointed as Audit Chair [BULLISH - governance improvement, ownership reset]
-
Appointed Dr. Jeong H. Kim (former Bell Labs President, Samsung board member, National Academy of Engineering) to board effective Oct 29; exceptional credentials suggest focus on innovation and technology strategy [BULLISH - board quality upgrade]
-
Elected Donald Slager (former Republic Services CEO, 2011-2021) as independent director; serves on Audit and Compensation Committees; brings deep industrial and governance expertise [BULLISH - board refreshment with proven operator]
-
Appointed two new directors and EVP/Chief Legal Officer as part of C-suite reorganization; strengthening governance and legal functions during transition period [NEUTRAL/BULLISH - proactive governance]
-
Appointed Shlomo Zakai as CFO at $13,000/month consulting fee; very low-cost CFO hire suggests cash conservation strategy [NEUTRAL - cost discipline but limited resources]
Risk Flags (8)
-
Company has a going concern qualification and faces potential delisting from NYSE American; CEO equity awards subject to stockholder and NYSE American approvals [HIGH RISK - survival risk]
- Matternet, Inc. (Los Altos Ventures)/CFO Departure▼
CFO Jason Secore departed Sept 29, 2026, with $156,146 separation cash and extended option exercise period until 18 months after Nasdaq/NYSE listing; departure timing suggests potential listing delays or internal issues [MEDIUM RISK - talent loss, listing uncertainty]
-
Chief Accounting Officer Prerna Sachdeva resigning effective Nov 2, 2026, to 'pursue other opportunities'; CFO taking interim role without additional comp; gap in accounting leadership during reporting period [MEDIUM RISK - reporting continuity risk]
-
Board member Craig Conway not standing for re-election at 2026 annual meeting; former President Tarkan Maner under Transition Advisory Agreement at $37,500/month for 12 months; multiple senior departures signal potential leadership vacuum [MEDIUM RISK - cumulative leadership loss]
-
Third CFO change in short period (Katharyn Field departed Aug 27, interim Grady Ryther, now William Witherspoon from board); new CFO stepping down from all committees; raises governance and stability concerns [MEDIUM RISK - instability in finance function]
-
Director William A. Jeffrey retiring at 2027 AGM (March 2027); no disagreement stated but loss of experienced board member; company also disclosed zero-coupon senior notes (TEL/29) which may indicate unusual financing [LOW RISK - gradual board transition]
-
Jill A. Crager, SVP of Sales and Marketing, retiring Dec 31, 2026, after 28 years; successor search initiated; loss of institutional knowledge in key commercial role [LOW RISK - transition risk]
-
Appointed Chen Wang with e-commerce and health management background; no disclosed compensation or related-party transactions; very small company with limited disclosure [LOW RISK - governance opacity]
Opportunities (8)
- Corteva, Inc./Spin-off Catalyst↓ (OPPORTUNITY)◆
Seed business spin-off (Vylor Inc.) completed Oct 1; remaining Corteva focused solely on crop protection with new CEO and board; potential for margin expansion and strategic M&A; watch for Q4 earnings to show separation benefits
- Boston Scientific Corp./COO Appointment & Restructuring↓ (OPPORTUNITY)◆
New COO Joseph Fitzgerald and three-segment structure effective Jan 1, 2027; Penumbra acquisition integration into Interventional Therapies; operational efficiency drive could drive margin expansion
- FuelCell Energy, Inc./CFO Upgrade↓ (OPPORTUNITY)◆
New CFO Matthew Latino from Xylem (large-cap industrial) and Deloitte; brings public company and Big 4 experience; $400K RSU grant aligns with shareholder value creation; outgoing CFO stays as advisor through April 2027 ensuring smooth transition
- Hims & Hers Health, Inc./Accounting Strengthening↓ (OPPORTUNITY)◆
New CAO Jonathan Franklin from Rivian and PwC with CPA credentials; $3M RSU grant indicates strong retention incentives; orderly transition with outgoing CAO in advisory role until July 2027; strengthens financial reporting credibility
- WillScot Holdings Corp/Board Expertise↓ (OPPORTUNITY)◆
Donald Slager (former Republic Services CEO) brings deep waste management and industrial expertise; Republic Services grew significantly under his leadership (2011-2021); could provide strategic guidance on operational efficiency and M&A
- Crane NXT, Co./Technology Expertise↓ (OPPORTUNITY)◆
Dr. Jeong H. Kim's appointment brings Bell Labs and Samsung board experience; National Medal of Technology recipient; could accelerate innovation strategy in payment and automation technologies
-
Former CEO selling entire stake (1.8M common + 625K preferred) to third-party investor; new independent director with 30+ years at Citigroup and KYC expertise; potential for complete governance overhaul and new strategic direction [OPPORTUNITY - speculative]
-
Two new directors and new EVP/Chief Legal Officer; 22 branches in NJ and 4 in NY; community bank with enhanced governance could attract regional consolidation interest [OPPORTUNITY - M&A target potential]
Sector Themes (6)
- Industrial Sector Board Refreshment◆
Three industrial companies (Crane NXT, WillScot, Armstrong World) announced board or senior leadership changes; all appointed directors with deep operational experience (former Bell Labs President, Republic Services CEO); suggests sector focus on operational excellence and technology adoption
- Orderly CFO Succession Planning◆
Multiple companies (FuelCell Energy, Alkami, Advasa) structured CFO transitions with advisory periods (6-12 months) and retention of outgoing executives; indicates proactive talent management rather than crisis departures; positive signal for corporate governance quality
- Spin-off and Restructuring Wave◆
Corteva's seed business spin-off and Boston Scientific's segment restructuring represent significant corporate actions; both involve board and leadership changes to align with new structures; trend toward simplification and focus may continue across industrials and healthcare
- Small-Cap Governance Upgrades◆
Several micro-cap companies (Northann, Incordex, BCB Bancorp) appointing new directors with strong credentials; suggests regulatory or investor pressure for improved board composition; potential catalyst for valuation re-rating if governance improvements materialize
- Equity Compensation as Retention Tool◆
Companies using significant equity grants to attract and retain talent (Hims & Hers $3M RSUs, FuelCell $400K RSUs, BiomX 2M+ shares); indicates competitive talent market for financial executives; high equity grants may signal growth expectations but also dilute existing shareholders
- Defense/Government Contracting Leadership Changes◆
Two companies (BiomX/Tessera, Nukkleus/T3 Defense) with defense/government focus announced CEO and CFO changes; both use consulting agreements and performance-based compensation; sector seeing leadership turnover as companies reposition for government contracts
Watch List (8)
-
First full quarter post-spin-off; watch for margin improvement in remaining crop protection business and new CEO Luke Kissam's strategic vision; expected early Feb 2027
-
CEO equity awards require stockholder and NYSE American approvals; going concern qualification and potential delisting; watch for shareholder vote on compensation plan and any Nasdaq/NYSE American compliance updates
-
New CFO Matthew Latino starts Oct 7; outgoing CFO Bishop remains advisor through April 2027; watch Q1 2027 earnings for first report under new CFO and any strategic changes
-
New COO and segment structure effective Jan 1, 2027; Penumbra acquisition integration; watch Q4 2026 earnings call for details on segment reporting and synergy targets
-
Chief Accounting Officer resigns Nov 2; CFO serving as interim; watch for announcement of permanent replacement and any delays in SEC filings during transition
-
Former CEO Lin Li selling entire stake pending paperwork completion; watch for announcement of transaction close and new investor's strategic plans; potential catalyst for governance overhaul
- Matternet, Inc. (Los Altos Ventures)/Nasdaq/NYSE Listing👁
CFO separation agreement includes extended option exercise period tied to exchange listing; watch for any S-1 filing or listing announcement; CFO departure may signal delays
-
Board member Craig Conway not standing for re-election; watch for any additional board departures or strategic changes; former President's advisory agreement runs 12 months
Filing Analyses
(17)
07-10-2026
Boston Scientific announced the appointment of Joseph M. Fitzgerald as Executive Vice President and Chief Operating Officer (COO), effective January 1, 2027, and the establishment of three new reportable segments—Interventional Therapies, Rhythm Solutions, and MedSurg—to increase efficiency and support continued growth. The new operating structure is designed to enable faster decision-making and strategic allocation of investments. The filing also notes that Lance Bates will lead Interventional Therapies, Nick Spadea-Anello will lead Rhythm Solutions, and Stephen Morse will lead MedSurg and Asia Pacific, all reporting to Fitzgerald.
- · The new segments are effective January 1, 2027.
- · Interventional Therapies will include the Penumbra business after the acquisition closes.
- · Fitzgerald currently serves as Executive Vice President and Group President, Cardiovascular.
07-10-2026
On October 6, 2026, TE Connectivity plc disclosed that Director William A. Jeffrey has decided to retire from the Board and will not stand for re-election at the Company's 2027 Annual General Meeting in March 2027. Mr. Jeffrey confirmed his decision did not involve any disagreement with the Company. The filing also lists the company's registered securities, including ordinary shares (TEL) and three series of senior notes (due 2028, 2029, and 2033) issued by a subsidiary.
- · Mr. Jeffrey's retirement is effective upon the 2027 Annual General Meeting in March 2027.
- · The 0.00% Senior Notes due 2029 (TEL/29) carry a zero percent coupon rate.
- · All senior notes are issued by Tyco Electronics Group S.A., an indirect wholly-owned subsidiary of TE Connectivity plc.
07-10-2026
Crane NXT, Co. (NYSE: CXT) announced the appointment of Dr. Jeong H. Kim to its Board of Directors, effective October 29, 2026. Dr. Kim brings extensive leadership experience from roles including Executive Chairman of Kiswe Mobile and former President of Bell Labs, and has served on the board of Samsung Electronics. The appointment is a routine board addition with no financial terms disclosed, and no negative or flat metrics are present.
- · Dr. Kim holds a Ph.D. in reliability engineering from the University of Maryland, a master's degree in technical management, and a bachelor's degree in electrical engineering and computer science from Johns Hopkins University.
- · He is a member of the National Academy of Engineering and a recipient of the National Medal of Technology and Innovation, France’s Legion of Honor, and the Horatio Alger Award.
- · The appointment is effective October 29, 2026.
07-10-2026
Incordex Corp. appointed Mr. Chen Wang, age 54, as a new member of its Board of Directors, effective September 29, 2026. Mr. Wang brings extensive e-commerce and health management experience, including a prior role where he delivered annual revenue of RMB1 billion. The appointment is a routine governance update with no disclosed compensation or related-party transactions.
- · Mr. Wang founded his own brand and has served as Founder and Chairman of Yunnan Jinshengchang Technology and Trade Co., Ltd. since October 2024.
- · Mr. Wang obtained an MBA in Health Management from Tsinghua University in 2015.
- · No family relationships exist between Mr. Wang and other directors or executive officers.
- · Mr. Wang is not a party to any transaction requiring disclosure under Item 404(a) of Regulation S-K.
- · The appointment is effective September 29, 2026, and the Director Offer Letter is dated the same day.
07-10-2026
Matternet, Inc. (formerly Los Altos Ventures Corp.) disclosed the departure of CFO Jason Secore, effective September 29, 2026, under a separation agreement dated October 1, 2026. The company will pay $156,146 in separation cash and extend the post-termination exercise period for vested stock options (ES-238 and ES-291) until 18 months after a Nasdaq/NYSE listing. The departure was not related to any disagreement with the company's operations, policies, or practices.
- · Separation Date: September 29, 2026
- · Separation agreement dated October 1, 2026
- · COBRA premium payments by company through October 31, 2026
- · Post-termination exercise period extended to 18 months after first Nasdaq/NYSE listing
- · No accrued vacation or PTO payout due to nonaccrual policy
- · Departure not related to any disagreement with company operations, policies, or practices
07-10-2026
Armstrong World Industries announced that Jill A. Crager, Senior Vice President of Sales and Marketing, will retire effective December 31, 2026, after 28 years of service. The company will begin a search for her successor, and Ms. Crager will continue leading her teams and assist with the transition until her retirement date.
- · Retirement effective December 31, 2026
- · Successor search process to be initiated
- · Ms. Crager will remain in role until retirement and assist with transition
07-10-2026
Hims & Hers Health, Inc. appointed Jonathan M. Franklin as chief accounting officer and principal accounting officer, effective October 9, 2026, succeeding Irene Becklund, who will transition to an advisory role until July 10, 2027. Mr. Franklin brings experience from Rivian and PwC and will receive a compensation package including a $425,000 base salary, a $150,000 signing bonus, and $3,000,000 in restricted stock units. The transition appears orderly, with no negative financial metrics reported.
- · Jonathan M. Franklin, 43, previously served as Vice President, Corporate Controller at Rivian from April 2024 to October 2026.
- · Mr. Franklin is a certified public accountant in Michigan and holds a BBA in Accounting and a Master of Accounting from the University of Michigan.
- · The signing bonus of $150,000 is payable in installments and subject to continued service for nine months.
- · The restricted stock unit grant of $3,000,000 vests 25% on the first quarterly vesting date after the one-year anniversary, with the remaining 75% vesting quarterly over three years.
- · Mr. Franklin is eligible for an annual discretionary bonus with a target of 50% of his base salary.
- · Severance benefits include nine months of salary and target bonus continuation (or twelve months in a change in control), plus health coverage and equity vesting.
- · Irene Becklund will support the Company under an advisory agreement from October 10, 2026, until July 10, 2027.
07-10-2026
Nutanix disclosed that board member Craig Conway will not stand for re-election at the 2026 annual meeting, with no disagreement with the company. Separately, the company entered a Transition Advisory Services Agreement with Tarkan Maner, who stepped down as President and Chief Commercial Officer, under which he will receive a monthly advisory fee of $37,500 for a twelve-month term. The filing reflects orderly board and executive transitions without financial surprises or negative performance metrics.
- · Craig Conway's decision not to stand for re-election is not due to any disagreement with Nutanix.
- · The Advisory Agreement has a twelve-month term, may be terminated for cause or by either party with 30 days' notice.
- · The Advisory Agreement does not provide severance, make-whole payments, new equity awards, or accelerated vesting.
- · Mr. Maner remains eligible to satisfy vesting requirements on outstanding equity awards during the advisory term.
07-10-2026
BCB Bancorp, Inc. announced the appointment of Steven E. Gallotta and Denny Kim to its board of directors, and Patricia M. Schaubeck as EVP, Chief Legal Officer and Corporate Secretary, as part of a C-suite reorganization. The appointments aim to strengthen governance and legal functions during a transition period. No financial metrics or performance data were disclosed in the filing.
- · Steven E. Gallotta will serve on the Audit Committee; Denny Kim will serve on the Nominating and Corporate Governance Committee.
- · Patricia M. Schaubeck's appointment is part of a reorganization of the legal department and C-suite.
- · The bank operates 22 branches in New Jersey and 4 branches in New York.
07-10-2026
Corteva, Inc. completed its separation into two independent companies, spinning off its seed operating segment as Vylor Inc. effective October 1, 2026. In connection with the separation, four directors (Charles V. Magro, Kerry J. Preete, Marcos M. Lutz, Karen H. Grimes) resigned from the board, and Luther "Luke" Kissam was appointed as a director and CEO. Additionally, four officers resigned and four new officers were appointed, including Jeff Rudolph as CFO, Brook Cunningham as CCO, and Ralph Ford as CIOO.
- · Separation effective at 12:03 a.m. New York City time on October 1, 2026.
- · New board committees: Audit (Chair: Patrick J. Ward), Governance and Compliance (Chair: Janet P. Giesselman), People and Compensation (Chair: David C. Everitt), Science and Innovation (Chair: Klaus A. Engel, Ph.D.).
- · No director or officer appointments are based on arrangements with other persons or transactions requiring disclosure under Item 404(a).
- · Biographical details and employment agreement for Mr. Kissam were previously filed in the April 8-K.
07-10-2026
Northann Corp. appointed Vincent La Scala as an independent director and Audit Committee Chair, replacing Umesh Patel. Separately, former CEO Lin Li agreed to sell all his beneficial securities (1,803,750 common shares and 625,000 Series A Preferred shares) to a third-party investor, which will result in Mr. Li holding no company securities after closing.
- · Vincent La Scala has over 30 years at Citigroup, most recently as Director, Independent Commercial Risk Management (2021-2023).
- · La Scala previously rebuilt Citi's Know Your Customer program across Latin American markets following severe regulatory criticism.
- · The sale of Lin Li's securities is pending completion of certain paperwork.
- · No familial or other relationships exist between La Scala and any director or management of the company.
07-10-2026
WillScot Holdings Corp announced the election of Donald Slager as an independent director, effective October 7, 2026, as part of its ongoing board refreshment. Slager, former CEO of Republic Services, brings extensive public company leadership and governance experience. He will serve on the Audit and Compensation Committees.
- · Slager served as President and CEO of Republic Services from 2011 to 2021.
- · He currently serves on the boards of Martin Marietta Materials and Eastman Chemical Company.
- · WillScot operates from approximately 240 branch locations in the U.S., Canada, and Mexico.
07-10-2026
FuelCell Energy announced the departure of CFO Michael S. Bishop effective October 6, 2026, and the appointment of Matthew Latino as the new Executive Vice President, CFO, and Treasurer effective October 7, 2026. Bishop will remain as Senior Advisor to the CEO through April 6, 2027, receiving a base salary of $461,591 during the transition and severance benefits. Latino brings experience from Xylem Inc. and Deloitte, with an annual base salary of $460,000, a target bonus of 70% of base salary, a sign-on bonus of $120,000, and a one-time RSU grant valued at $400,000.
- · Michael Bishop's transition period ends April 6, 2027 (Separation Date).
- · Bishop will receive a pro-rated performance bonus during transition (not to exceed 100% of target) but no new equity awards.
- · All unearned performance stock units and other unvested equity awards held by Bishop as of Separation Date will be forfeited, except for pro-rata PSUs and accelerated RSUs.
- · Matthew Latino, age 41, previously served as SVP, Finance & Segment CFO at Xylem Inc. from November 2025 to June 2026.
- · Latino's target long-term incentive award for FY2027 is $1,000,000, split 50% performance share units (3-year cliff vest) and 50% time-vesting RSUs.
- · Latino's severance in case of termination without cause (non-change-in-control) includes 12 months base salary plus COBRA premiums for up to 12 months.
- · In a change-in-control termination, Latino receives one year base salary plus target annual bonus, plus COBRA premiums for up to 12 months.
07-10-2026
Alkami Technology, Inc. announced the resignation of Chief Accounting Officer Prerna Sachdeva, effective November 2, 2026, to pursue other opportunities. CFO Cassandra Hudson will serve as interim principal accounting officer starting November 3, 2026, without additional compensation, while the company conducts a search for a permanent replacement. The resignation was personal and not due to any disagreement with the company.
- · Ms. Sachdeva will assist with transition through November 2, 2026.
- · Ms. Hudson will assume the principal accounting officer role on an interim basis starting November 3, 2026.
- · Ms. Hudson will not receive additional compensation for the interim role.
- · No family relationships or related-party transactions requiring disclosure were noted.
07-10-2026
Tessera Defense and Homeland Security Inc. (formerly BiomX Inc., NYSE American: HLSQ) announced an employment agreement with CEO Michael Oster, including options for 1,000,000 shares at $1.15, 1,000,000 RSUs vesting over three years, 400,000 fully vested shares, and performance-based awards tied to EBITDA per share for FY2027 and FY2028. The company has raised over $6 million in net proceeds from its ATM offering and secured a $5 million line of credit, but the awards are subject to stockholder and NYSE American approvals, and the company faces risks including a going concern qualification and potential delisting from NYSE American.
- · The employment agreement is with Tessera's wholly owned Israeli subsidiary.
- · Mr. Oster was appointed CEO as of March 4, 2026.
- · For FY2028, the performance award structure applies above a threshold of $0.10 EBITDA per share, also up to a maximum of 500,000 shares.
- · All equity awards are subject to stockholder approval of an increase in shares under the 2026 Equity Incentive Plan and NYSE American approval of listing.
- · The Special Meeting of Stockholders is scheduled for October 20, 2026.
- · The company has a going concern qualification and risks of not regaining compliance with NYSE American continued listing standards.
- · The company transitioned from biotechnology to defense and homeland security technology and completed acquisitions of Zorronet and DFSL.
07-10-2026
T3 Defense Inc. (formerly Nukkleus Inc.) appointed Shlomo Zakai as Chief Financial Officer effective October 5, 2026. Mr. Zakai will receive $13,000 per month plus VAT under a consulting agreement that can be terminated by either party with 30 days' notice. The filing does not disclose any financial results or performance metrics, so no positive or negative trends are reported.
- · Mr. Zakai, 56, previously served as CFO of Duke Robotics Corp. from May 2020 to October 2026 and as CFO of Save Foods, Inc. from August 2017 to December 2021.
- · He holds a B.A. in accounting from the College of Management in Rishon Le’Zion, Israel.
- · No family relationships or material interests in transactions requiring disclosure were reported.
07-10-2026
Advasa Holdings, Inc. appointed William Witherspoon as Chief Financial Officer effective October 6, 2026, replacing interim CFO Grady Ryther. Witherspoon, previously an independent director, will receive an annual base salary of $200,000 and is eligible for discretionary bonuses and equity grants. He will step down from the Audit, Compensation, and Nominating Committees as part of the transition.
- · William Witherspoon has served as an independent director since June 24, 2026.
- · Prior CFO Katharyn Field departed on August 27, 2026.
- · Witherspoon holds an MBA from George Washington University and a BS from the University of Georgia.
- · Employment agreement is at-will with a 30-day resignation notice requirement.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 17 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Corporate Board Director Changes SEC Filings
September 28, 2026
US Corporate Board Director Changes SEC Filings — September 28, 2026
September 25, 2026
US Corporate Board Director Changes SEC Filings — September 25, 2026
September 24, 2026
US Corporate Board Director Changes SEC Filings — September 24, 2026
September 23, 2026
US Corporate Board Director Changes SEC Filings — September 23, 2026
🇺🇸 More from United States
View all →September 29, 2026
US Pre-Market SEC Filings Roundup — September 29, 2026
US Pre-Market SEC Filings Roundup
September 29, 2026
US SEC Filings Daily Market Digest — September 29, 2026
US SEC Filings Daily Market Digest
September 29, 2026
S&P 500 Technology Sector SEC Filings — September 29, 2026
S&P 500 Technology Sector SEC Filings
September 29, 2026
US Material Events SEC 8-K Filings — September 29, 2026
US Material Events SEC 8-K Filings